| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | HKEX Exchange | KYG5438W1116 ISIN |
| Hong Kong Country | 1,094 Employees | 27 May 2026 Last Dividend | - Last Split | - IPO Date |
Lee's Pharmaceutical Holdings Limited is a distinguished investment holding entity focused on the realm of pharmaceutical development, manufacturing, marketing, and distribution, mainly within the People's Republic of China. Founded in 1994 and anchored in Sha Tin, Hong Kong, this company prides itself on addressing a broad spectrum of health concerns through its innovative pharmaceutical solutions. Its commitment spans across various disease areas such as cardiovascular health, woman health, paediatrics, rare diseases, oncology, dermatology, and obstetrics. Operationally, Lee's Pharmaceutical bifurcates its offerings into two primary segments: Proprietary and Generic Products; and Licensed-In Products. Through these segments, the company offers a comprehensive range of pharmaceutical products, from self-developed and generic medications to licensed-in drugs, aimed at tackling a plethora of health conditions and contributing significantly to patient care and wellness.
The extensive product lineup of Lee's Pharmaceutical Holdings Limited is categorically divided to cater to varying health needs with precision and efficacy: